Please assess the completion status of the following clinical trial:

Trial Title: GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject is either:~   * Symptomatic (amaurosis fugax in the hemisphere supplied by the target vessel, TIA or non-disabling stroke within 6 months of the procedure) with carotid stenosis ≥50% as diagnosed by angiography using NASCET methodology, OR~  * Asymptomatic with carotid stenosis ≥80% as diagnosed by angiography using NASCET methodology~2. Target lesion is located in one of the following:~   * ICA~  * bifurcation~  * CCA proximal to the bifurcation~3. At Anatomic risk for adverse events from CEA (e.g., restenosis after a prior CEA) or at Co-morbid risk for adverse events from CEA (e.g., unstable angina with ECG changes)~Exclusion Criteria:~* Recent surgical procedure within 30 days before or after the stent procedure~* Uncontrolled sensitivity to contrast media~* Renal Insufficiency~* Recent evolving, acute stroke within 21 days of study evaluation~* Myocardial infarction within 72 hours prior to stent procedure~* History of a prior major ipsilateral stroke with residual neurological deficits likely to confound the neurological assessments (e.g., NIHSS)~* Neurological deficits not due to stroke likely to confound the neurological assessments (e.g., NIHSS)~Angiographic Exclusion Criteria:~* Isolated ipsilateral hemisphere leading to subject intolerance to reverse flow~* Total occlusion of the ipsilateral carotid artery~* Pre-existing stent in the ipsilateral carotid artery OR the contralateral carotid artery that extends into the aortic arch~* Presence of a filling defect, thrombus, occlusion or string sign in the target vessel~* Severe lesion calcification restricting stent deployment~* Carotid stenosis located distal to target stenosis that is more severe than target stenosis~* \>50% stenosis of the CCA proximal to target vessel~* Known mobile plaque in the aortic arch

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- GORE® Embolic Filter (Type: EXPERIMENTAL): Subjects treated with the GORE® Embolic Filter and an FDA-approved carotid stent.

Based on this trial design, predict the completion outcome and termination type (if applicable).